2型糖尿病微血管病变,Micro-vascular disease
1)Micro-vascular disease2型糖尿病微血管病变
英文短句/例句

1.Analysis of Risk Factors of Diabetic Microvascular Complication in Type 2 Diabetes;2型糖尿病微血管病变危险因素的分析
2.The changes of markers to prethrombotics tate in patients with type 2 diabetes microangiopathy血栓前状态分子标志物在2型糖尿病微血管病变中的变化
3.Relationship between C-peptide and Type-2 Diabetes Microangopathy in Different Durations不同病程中C-肽与2型糖尿病微血管病变的相关性
4.Association of Beta 3-Adrenergic Receptor Gene Polymorphism with Microvascular Complications in Type 2 Diabetic Patients;β_3-AR基因多态性与2型糖尿病微血管病变的相关性研究
5.Association of Levels of SAA, CRP, FIB with Insulin Resistance and Microvascular Complications of T2DMSAA、CRP、FIB与胰岛素抵抗及2型糖尿病微血管病变的相关研究
6.The Relationship between Plasma Resistin with Type 2 Diabetes Mellitus and Diabetic Microangiopathy;血浆抵抗素与2型糖尿病、糖尿病微血管病变的相关性研究
7.The Pathogenesis of Type 2 Diabetes Macrovascular Disease and the Treatment of Diabetes Mellitus;2型糖尿病大血管病变机理和糖尿病治疗
8.A Study about the Plasma Adiponectin Levels and Macroangiopathy in Patients with Type 2 Diabetes Mellitus;脂联素与2型糖尿病大血管病变研究
9.Serum Level of sTNFR2 and Type 2 Diabetes Mellitus with Macroangiopathy;sTNFR2与2型糖尿病大血管病变
10.The Changes of Four Platelet Parameters in Type 2 Diabetic Patients and its Correlation with Microangiopathy Disease血小板参数在2型糖尿病患者中的变化及与微血管病变的关系
11.The Relation of Microalbuminuria Urine and Macrovascular Complications in Type 2 Diabetes Mellitus;尿微量蛋白与2型糖尿病大血管病变的关系研究
12.The Relationships between Serum Amyloid A and Microvascular Complications of Type 2 Diabetes血清淀粉样蛋白A与2型糖尿病及其微血管病变的研究进展
13.Clinical research of vascular endothelial function change in type 2 diabetes patients2型糖尿病患者血管内皮功能的改变
14.Weight Rank Sum Ratio (WRSR) Comprehensive Evaluation Used in Effect Comprehensive Evaluation in Forepart Micro Vascular Complication in Type 2 Diabetes Mellitus Treating by Traditional Chinese Medicine (TCM);2型糖尿病早期微血管病变中医疗效的加权秩和比(WRSR)综合评价
15.The Research on Microangiopathy and Immune Function in Type 2 Diabetes Mellitus Patients with Black Patches on Pre-tibia;2型糖尿病胫前黑斑患者微血管病变及免疫功能的探讨
16.The Relationship of Plasma Adiponectin and Diabetic Angiopathy in Type 2 Diabetes Mellitus Patients;2型糖尿病患者血浆脂联素水平与糖尿病血管病变的相关性研究
17.The Study on the Relationship of Serum HGF and Type 2 Diabetic Cadiovascullar Disease;血清HGF水平与2型糖尿病心血管病变的研究
18.The Study of Bone Mineral Density and Lower Extremity Vascular Disease in Type 2 Diabetic Patients;2型糖尿病下肢血管病变与骨密度的相关研究
相关短句/例句

Type Ⅱ Diabetes Mellitus Macrovascular Complications2型糖尿病大血管病变
1.Effects of Shenqi Compound Recipe on CD36 mRNA and ox-LDL in GK Rats with Type Ⅱ Diabetes Mellitus Macrovascular Complications;参芪复方对GK大鼠2型糖尿病大血管病变CD36 mRNA及ox-LDL的影响
3)Vascular lesion of TYPE 2 DM2型糖尿病血管病变
4)Diabeticmicrovascular complication糖尿病微血管病变肾病
5)Diabetic microangiopathy糖尿病微血管病变
1.Experiment study on Erhuang Huoxue decoction in preventing and treating diabetic microangiopathy;二黄活血汤防治糖尿病微血管病变的实验研究
2.Relations between diabetic microangiopathy and endothelin and von Willebrand factor;糖尿病微血管病变与血浆内皮素及血管性假血友病因子的关系
3.Methods Fasting serum leptin (with RIA), insulin (with RIA) and fasting blood glucose (with oxidase method) levels were measured in 30 controls, 30 diabetic patients without microangiopathy and 30 patients with diabetic microangiopathy.方法 :对照组、糖尿病无微血管病变组及糖尿病微血管病变组各 30例 ,其中糖尿病微血管病变组包括糖尿病肾病 2 5例 ,糖尿病视网膜病变 12例 ,同时合并DN与DR者 7例。
6)Diabetic renal microangipathy糖尿病肾微血管病变
1.Objective:To investigate the clinical significance of serum P-selection、TNF-a、hs-CRP in patients with Diabetic renal microangipathy, and the therapeutic mechanism of Simvastatin、Aspirinon.目的:探讨糖尿病肾微血管病(Diabetic renal microangipathy,DN)患者血浆肿瘤坏死因子-a (tumor necrosis factor-a,TNF-a)、超敏C反应蛋白(Hypersen- sitivity C-Reactive Protein,hs-CRP)、P-选择素(P-selection)的临床意义及辛伐他汀、阿司匹林、辛伐他汀联合阿司匹林对糖尿病肾微血管病变患者的影响及可能的机制。
延伸阅读

[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]分子式:C16H16ClN3O3S分子量:365.5CAS号:26807-65-8性质:暂无制备方法:暂无用途:用于轻、中度原发性高血压。